Candesartan in the prevention of relapsing atrial fibrillation
- 9 August 2007
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 120 (1) , 85-91
- https://doi.org/10.1016/j.ijcard.2006.08.086
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)American Heart Journal, 2005
- Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenololJournal of the American College of Cardiology, 2005
- Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillationJournal of the American College of Cardiology, 2004
- Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular DysfunctionCirculation, 2003
- Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5‐year follow‐up of 268 consecutive patientsScandinavian Cardiovascular Journal, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Ablation therapy for atrial fibrillation (AF) Past, present and futureCardiovascular Research, 2002
- Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular DysfunctionCirculation, 1999
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of internal medicine (1960), 1995